Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmadrug Inc
C.PHRX
Alternate Symbol(s):
LMLLF
Medical Care
Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural...
medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PHRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2864)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Apr 01, 2022 8:28am
Pharmadrug Advances PD-001
Committed to the 'pipeline-in-a-pill' approach with PD-001 for certain cancers and COVID-19 Advances cGMP manufacturing of clinical drug supply with Southwest Research Institute
...more
(11)
•••
swim
X
View Profile
View Bullboard History
Post by
swim
on Mar 03, 2022 12:46pm
Just noticed
there's some increased volume, & an uptick in the PPS.
(11)
•••
swim
X
View Profile
View Bullboard History
Post by
swim
on Feb 23, 2022 8:40am
PharmaDrug Receives Positive Results for DMT-Analogue Progra
PharmaDrug receives encouraging potency data for candidate DMT-analogue molecules designed to treat primary open angle glaucoma Terasaki Institute advances PharmaDrug's candidate DMT-analogue
...more
(38)
•••
Blahblahblahbla
X
View Profile
View Bullboard History
Post by
Blahblahblahbla
on Feb 01, 2022 7:48am
Great News Release today
News Press Releases PharmaDrug Announces Filing of US Provisional Patent for Cepharanthine to Treat Prostate Cancer C.PHRX | 16 minutes
...more
(3076)
•••
Goldy63
X
View Profile
View Bullboard History
Comment by
Goldy63
on Jan 26, 2022 1:00pm
RE:PharmaDrug Announces Initiation of Manufacturing of Cepharan
Getting very interesting here . Drugs to treat a whole host of medical problems . Love It. Cepharanthine has been shown to exhibit multiple pharmacological properties including anti-oxidative, anti
...more
(11)
•••
swim
X
View Profile
View Bullboard History
Comment by
swim
on Jan 26, 2022 10:02am
RE:New Cohen interview on Wall Street Reporter
Worthwhile watching. I watched it yesterday, & was impressed with what both of them had to say.
(11)
•••
swim
X
View Profile
View Bullboard History
Post by
swim
on Jan 26, 2022 9:59am
PharmaDrug Announces Initiation of Manufacturing of Cepharan
PharmaDrug Announces Initiation of Manufacturing of Cepharanthine (PD-001) For Clinical Programs in Rare Cancers And COVID-19 Establishing cGMP supply for IND-enabling and up to Phase 2
...more
(15)
•••
SamRothstein
X
View Profile
View Bullboard History
Post by
SamRothstein
on Jan 25, 2022 10:02pm
New Cohen interview on Wall Street Reporter
Next Super Stock video with Cohen and Paul Van Slyke (Chief Science Officer). https://www.youtube.com/watch?v=g5-iBiQlSmY
(16)
•••
nohair
X
View Profile
View Bullboard History
Comment by
nohair
on Jan 25, 2022 8:11pm
RE:PHRX. - Pharmadrug (Great Volumes with a question mark)
340 million shares outstanding last split August 2 2016 always a chance hopefully not
(1)
•••
Pamplona168
X
View Profile
View Bullboard History
Post by
Pamplona168
on Jan 25, 2022 10:57am
PHRX. - Pharmadrug (Great Volumes with a question mark)
Why do some people keep adding hundreds of thousands of PHRX on the SELL side after SELLS have been taken out? Is there any risk of a consolidation of shares? Insiders usually know this long before
...more
(8)
•••
ssyringa
X
View Profile
View Bullboard History
Comment by
ssyringa
on Jan 24, 2022 3:26pm
RE:RE:Dan's new interview !!
https://www.youtube.com/watch?v=VY3H1ZMDuOg maybe this will work
(8)
•••
ssyringa
X
View Profile
View Bullboard History
Comment by
ssyringa
on Jan 24, 2022 3:18pm
RE:Dan's new interview !!
sorry link didn't work
(8)
•••
ssyringa
X
View Profile
View Bullboard History
Post by
ssyringa
on Jan 24, 2022 3:06pm
Dan's new interview !!
https://www.youtube.com/watch?v=7TtTR9DERkM
(20)
•••
Hammer1
X
View Profile
View Bullboard History
Post by
Hammer1
on Jan 21, 2022 2:25pm
7.2 Mill Traded....
OK It's a down day in general (of course) for the markets. Would have loved to see what would have traded if the general market centiment was up. GL H
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed
EnviroGold Global Announces Appointment of Chief Operating Officer